Skip to Content Facebook Feature Image

Within3 Appoints Kyle Clifton as Vice President, Customer Value & Growth

Business

Within3 Appoints Kyle Clifton as Vice President, Customer Value & Growth
Business

Business

Within3 Appoints Kyle Clifton as Vice President, Customer Value & Growth

2026-11-18 00:10 Last Updated At:00:30

BOSTON--(BUSINESS WIRE)--Nov 17, 2026--

Within3, whose platform is trusted by all of the top 20 pharma companies to turn public data, private data, and expert networks into decision-ready evidence, today announced the appointment of Kyle Clifton as Vice President, Customer Value & Growth. In this role, Clifton will help clients define, measure, and receive the value that Within3’s technology and expertise provide. He brings more than 18 years of experience in biopharma commercial strategy, pricing, and market access, guiding assets from early evaluation through U.S. commercialization across rare diseases and oncology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261117347377/en/

Most recently, Clifton served as Managing Director at Red Nucleus, a global life sciences agency, where he led market access and commercial strategy engagements across various therapeutic areas. Earlier, he held consulting roles at Promidian Consulting, Boston Healthcare Associates, and Covance, and began his career on the front lines of the market as a Professional Sales Representative at Merck and an Account Manager for Medicare Part D at CVS Caremark. Clifton holds a Master of Business Administration and a Master of Health Sector Management from the W. P. Carey School of Business at Arizona State University, and a Bachelor of Arts in Business Administration from Rhodes College.

“Every client conversation comes back to two questions: how will this therapy reach the patients who need it, and what will make it succeed?” said Erin Mistry, Chief Executive Officer of Within3. “Kyle has spent his career answering both, across commercial strategy, M&A, pricing, access, and launch. He turns evidence into value that payers, providers, and patients recognize. We are excited to have him partnering with our clients and their investors to drive broader access and stronger commercial results.”

“Growth comes from clients who see measurable value in the partnership and keep finding new ways to put it to work,” said Ira Daly, who recently joined Within3 as Chief Operating Officer. “Kyle has worked alongside biopharma teams on their toughest decisions: which indication to prioritize, how to price an asset, and what evidence will drive payer access and HCP adoption. He pairs deep market access and commercial expertise with a talent for building value through creative solutions, which will help our clients turn evidence into specific actions that capture opportunities and mitigate risk.”

“I’ve spent my career helping biopharma teams make high-stakes commercial, pricing, and access decisions, often with an incomplete picture of the market,” said Clifton. “Within3 closes that gap with a connected, real-time view of the clinical and commercial landscape. I’m excited to help clients leverage insights from this technology and see its impact on outcomes, access, and, ultimately, the patients these therapies are meant to serve.”

As Vice President, Customer Value & Growth, Clifton will connect Within3’s decision-ready evidence directly to the commercial and market access questions that shape clients’ portfolios, identify new opportunities to apply it across lifecycle stages, and bring market access and commercialization expertise to client partnerships.

About Within3

Trusted by all of the top 20 pharmaceutical companies, Within3 delivers decision-ready evidence by uncovering the hidden influencers shaping clinical practice and capturing market shifts as they emerge, all in a shared, compliant view.

Within3 welcomes Kyle Clifton as its new VP, Customer Value & Growth

Within3 welcomes Kyle Clifton as its new VP, Customer Value & Growth

LONDON (AP) — A dispute over the sale of David Beckham perfumes has struck a sour note with the soccer star turned style icon.

Beckham’s commercial company is suing a beauty firm after his “luxury” fragrances were allegedly found for sale in discount stores and a gas station bargain bin.

DB Ventures has filed a claim in the New York Supreme Court against German beauty group Coty, which makes and distributes a range of Beckham-branded fragrances and toiletries. They include the Classic and Instinct lines and the eaux de toilette Intimately and Exquisite Leather.

The claim argues that Beckham’s “world-renowned global brand is synonymous with excellence and refinement,” and “David Beckham products are a symbol of everyday luxury.”

“Imagine, then, the shock and dismay experienced when DB Ventures discovered that David Beckham products were being offered for sale in a gas station,” the legal document says. “How could this possibly have happened? Desperation and greed.”

Lawyers for DB Ventures allege that Beckham-branded products “ended up in the bargain bin inside a gas station” and at British budget retailer Poundland, “allowing the product to be sold for dollar store prices and associating the David Beckham brand with cheap, discount products.”

DB Ventures is seeking at least $41 million in damages for breach of its licensing agreement.

Coty has asked a judge to dismiss the lawsuit, which was filed in April. The company argues that New York courts have no jurisdiction in the case, and says DB Ventures is using the claim to “manufacture its early exit” from its licensing deal and hand over the Beckham contracts to another firm, Interparfums.

The company told The Associated Press on Tuesday that “Coty strongly disputes the claims and has asked the court to dismiss them. As this is an ongoing legal matter, we will not comment further.”

DB Ventures' parent company, U.S. entertainment and lifestyles firm Authentic Brands, declined to comment.

Beckham, who played for a number of clubs including Manchester United and Real Madrid and captained the England men’s national team, parlayed success on the pitch into a lucrative business career that includes co-ownership of soccer team Inter Miami. He was knighted last year by King Charles III, becoming Sir David.

He also has had a very public persona as a fashion model, “Bend It Like Beckham” movie muse and husband of Spice Girl-turned-fashion designer Victoria “Posh Spice” Beckham. The couple have four children.

The Sunday Times Rich List earlier this year estimated the Beckhams' wealth at almost 1.2 billion pounds ($1.58 billion).

FILE -David Beckham poses with his new star during a ceremony on the Hollywood Walk of Fame on June 12, 2026, in Los Angeles. (AP Photo/Chris Pizzello, File)

FILE -David Beckham poses with his new star during a ceremony on the Hollywood Walk of Fame on June 12, 2026, in Los Angeles. (AP Photo/Chris Pizzello, File)

Recommended Articles